Pipeline Overview
Genvor’s BioCypher platform has generated a comprehensive pipeline of peptide solutions targeting agriculture’s most critical challenges and human health and wellness opportunities. From anti-pathogen protection to enhanced nutrition to consumer recovery and wellness, our pipeline demonstrates cross-market scalability and multiple deployment pathways.
Genvor’s AI-driven R&D pipeline combines molecular design, a, and scalable rollout to accelerate innovation in agricultural biotech.
Discovery
Proof of Concept
Joint Development Agreements
In Vitro & Field Trials
Commercial Licensing & Regulatory Approval
Product Launch
Human Health & Wellness Pipeline
Discovery
Formulation (IN PROGRESS)
Safety & Substantiation
Commercial Manufacturing
Launch
anti-aging
daily wellness
targeted recovery formulations
From Molecule to Market
AI-Driven Innovation for Sustainable Agriculture and Human Wellness
Genvor combines AI peptide design, USDA-backed validation, and commercial licensing to bring safe, effective crop and wellness solutions to market.
Targeted Peptides. Broad Impact.
- AMPs
- Strengthen plant immunity with residue-free disease control
- NEPs
- Boost protein quality and quantity
- CEPs
- Boost nutrient uptake
From Discovery to Deployment
- Design
- AI models generate high-efficiency peptides
- Validate
- Field-tested in collaboration with the USDA
- Deploy
- Licensed for scalable use across global agriculture
Phase-by-Phase Breakdown from Discovery to Deployment
Phase 1
AI-DrivenPeptide Discovery
Designing nature-inspired molecules through advanced computation for agriculture and human health
- BioCypher designs peptides for disease resistance, nutrient uptake, crop resilience, and human recovery and wellness
- AI modeling predicts structure-function relationships for high-efficiency outcomes
- Computational screening ensures targeted bioactivity with minimal environmental impact
- Large peptide libraries enable cross-crop adaptability and multi-trait stacking
Phase 2
Proof of Concept& Field Trials
Validating performance through USDA-led agricultural trials and human health formulation development
- USDA collaboration supports greenhouse and field validation across crops and climates
- Trials measure disease resistance, nutrient uptake, and environmental durability
- Transgenic traits encode peptides directly into seeds for scalable deployment
- Consumer health formulations undergo safety, stability, and bioavailability testing
- Early regulatory engagement aligns with EPA, USDA, and OTC compliance standards
Phase 3
Commercial Licensing& Deployment
Scaling innovation through capital-light, partnership-driven growth across agriculture and consumer health
- Licensing model accelerates adoption via Tier-1 ag and biotech partnerships
- Traits and sprays integrate seamlessly into existing agricultural systems
- Consumer health products target DTC and specialty retail channels through strategic wellness partnerships
- Applications span biological fungicides, transgenic seed innovations, OTC nasal peptide delivery and other formats
- Robust IP protections ensure long-term market exclusivity and value capture
From Molecule to Market
A Patent-Backed Peptide Platform Built for Rapid Adoption
Genvor’s 50K+ peptide library is backed by strong IP, securing exclusivity and market edge.
Key innovations include:
- AI-Powered Design Accelerating precision bioengineering for crop protection and performance through AI/ML-driven peptide discovery.
- Next-Gen Bio-Stimulants Designer peptides that enhance crop yield, resilience, and overall plant health using targeted biological stimulation.
- Protected Innovation Patent-backed peptides for antimicrobial, seed trait, and nutrient applications—ensuring lasting competitive edge.
Genvor’s licensing model enables partners to:
- Scale quickly with plug-and-play access to AI-driven peptide discovery.
- Reduce R&D costs with fee reimbursements and milestone-based structures.
- Unlock new revenue through predictable, royalty-based income tied to product performance.